Provide Your Feedback on The Bleeding Edge MD+DI would like to hear your perspectives on the documentary. Your responses to the following questions will be kept anonymous, and we will share them anonymously in an upcoming article. Thank you for your time! OK Question Title * 1. The Bleeding Edge claims that FDA's 510(k) process, reportedly the most popular way medical devices reach the U.S. market, doesn’t require the submission of as much safety data as does the premarket approval (PMA) process. Do you believe this is a fair depiction? Yes No Please feel free to explain your answer: OK Question Title * 2. Please select any of the following suggestions that you believe could reduce risks to patients: Overhaul the regulatory process to require more upfront safety data for 510(k) submissions Require longer postmarket surveillance studies on the safety of 510(k) cleared products Eliminate the 510(k) process Bar FDA staff from joining industry or vice versa Bar doctors from accepting compensation from medical device companies No regulatory changes are needed Other (please specify) OK Question Title * 3. What lessons can be learned from this documentary? OK DONE